Sona Nanotech Inc (TSE:SONA)
:SONA
SONA Stock Chart & Stats
C$0.40
>-C$0.01(-2.00%)
At close: 4:00 PM EST
C$0.40
>-C$0.01(-2.00%)
Day’s Range― - ―
52-Week RangeC$0.25 - C$0.91
Previous CloseN/A
Volume36.80K
Average Volume (3M)124.26K
Market Cap
C$35.46M
Enterprise ValueC$35.64M
Total Cash (Recent Filing)C$125.95K
Total Debt (Recent Filing)C$307.74K
Price to Earnings (P/E)―
Beta1.16
Next Earnings
Jun 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding114,375,250
10 Day Avg. Volume87,178
30 Day Avg. Volume124,263
Financial Highlights & Ratios
PEG Ratio-2.88
Price to Book (P/B)-1.80K
Price to Sales (P/S)0.00
P/FCF Ratio-35.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.06
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Proprietary Gold Nanorod TechnologySona's proprietary gold nanorod platform is a durable competitive asset: it supports multiple diagnostics and assay formats, creating a platform business that can scale across applications. Platform IP and specialized materials underpin long-term product pipeline and partnership potential.
Modest Absolute Debt And Deleveraging TrendLow absolute debt and a multi-year downward trend reduce leverage risk and preserve financial flexibility. Even with operating losses, a modest debt load eases near-term solvency pressure and makes future financing or strategic transactions less constrained by high fixed obligations.
Lean Operating Structure (small Team)A small, focused employee base suggests a lean cost structure and nimble R&D capability. For early-stage, IP-driven firms this reduces fixed payroll burn, helps conserve cash, and enables targeted development efforts that can extend runway between financings.
Bears Say
No Reported Revenue Across PeriodsZero reported revenue over multiple years is a structural weakness: it indicates the company has not yet commercialized products at scale. Lack of sales undermines self-sustaining cash generation and forces reliance on external funding to progress commercialization and scale operations.
Persistent Losses And Accelerating Cash BurnConsistent negative operating and free cash flow, with worsening FCF, signals structural cash-burn that will require repeated funding. This constrains discretionary R&D, commercialization investments and increases dilution or solvency risk if financing markets tighten over the medium term.
Deteriorated Balance Sheet And Negative EquityNegative equity and a sharp asset decline materially weaken the balance sheet, reducing capital buffer and raising solvency concerns. This structural deterioration limits borrowing capacity, increases cost of capital, and can hamper long-term strategic options and partner confidence.
Sona Nanotech Inc News
SONA FAQ
What was Sona Nanotech Inc’s price range in the past 12 months?
Sona Nanotech Inc lowest stock price was C$0.25 and its highest was C$0.91 in the past 12 months.
What is Sona Nanotech Inc’s market cap?
Sona Nanotech Inc’s market cap is C$35.46M.
When is Sona Nanotech Inc’s upcoming earnings report date?
Sona Nanotech Inc’s upcoming earnings report date is Jun 25, 2026 which is in 84 days.
How were Sona Nanotech Inc’s earnings last quarter?
Currently, no data Available
Is Sona Nanotech Inc overvalued?
According to Wall Street analysts Sona Nanotech Inc’s price is currently Overvalued.
Does Sona Nanotech Inc pay dividends?
Sona Nanotech Inc does not currently pay dividends.
What is Sona Nanotech Inc’s EPS estimate?
Sona Nanotech Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sona Nanotech Inc have?
Sona Nanotech Inc has 114,375,250 shares outstanding.
What happened to Sona Nanotech Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sona Nanotech Inc?
Currently, no hedge funds are holding shares in TSE:SONA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sona Nanotech Inc
Sona Nanotech Inc., nanotechnology life sciences company, manufactures and sells gold nanorod products for diagnostic tests. The company also provides Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in saliva specimens from individuals, who are suspected of COVID-19; Gemini gold nanorods; Omni gold nanorods for medical applications; and contract services. Its products are used in various applications, including drug delivery, food and beverage testing, environmental testing, cell imaging, cancer treatment, and liposuction therapy, as well as medical and consumer, military, and veterinary diagnostics. The company is based in Halifax, Canada.
Technical Analysis
BioMark Diagnostics
―
Eastwood Bio-Medical Canada
―
StageZero Life Sciences Ltd
―
Medmira
―
ZYUS Life Sciences
―
Options Prices
Currently, No data available
---